Paper337487
Posttranslational covalent modification of proteins.
Uy R and 1 other. Science, 1977. Cited by 285 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Posttranslational covalent modification of proteins. Papers, record 337487. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/337487
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Protein Precursors | Major topic |
| Proteins | Major topic |
| Amino Acid Sequence | |
| Amino Acids | |
| Cytosol | |
| Enzymes | |
| Hydrolysis | |
| Protein Biosynthesis | |
| RNA, Transfer | |
| Substrate Specificity |
Source PubMed
Cited by82
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 285 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,249,270 | Hydrogen sulfide-mediated protein s-persulfidation: a regulatory mechanism in cardiovascular homeostasis. | Mol Med | 2026 | https://conductscience.org/library/papers/42249270 | PubMed |
| 42,183,207 | Succinylation in cancer immunotherapy: mechanisms, biomarkers, and therapeutic implications. | Front Immunol | 2026 | https://conductscience.org/library/papers/42183207 | PubMed |
| 41,373,704 | Emerging Roles of Post-Translational Modifications in Metabolic Homeostasis and Type 2 Diabetes. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41373704 | PubMed |
| 41,350,808 | Probing tau citrullination in Alzheimer's disease brains and mouse models of tauopathy. | Acta Neuropathol | 2025 | https://conductscience.org/library/papers/41350808 | PubMed |
| 41,140,820 | XXYLT1 inhibits NOTCH1 activation in Jurkat cells while promoting cell proliferation. | Nagoya J Med Sci | 2025 | https://conductscience.org/library/papers/41140820 | PubMed |
| 41,090,352 | Citrullination in tumor immunity and therapy. | J Clin Invest | 2025 | https://conductscience.org/library/papers/41090352 | PubMed |
| 40,720,394 | Lactylation and viral infections: A novel link between metabolic reprogramming and immune regulation. | PLoS Pathog | 2025 | https://conductscience.org/library/papers/40720394 | PubMed |
| 40,267,484 | Implications of Protein Posttranslational Modifications in Sepsis-Induced Acute Lung Injury and Acute Respiratory Distress Syndrome. | Shock | 2025 | https://conductscience.org/library/papers/40267484 | PubMed |
| 38,540,730 | Post-Translational Modifications and Diabetes. | Biomolecules | 2024 | https://conductscience.org/library/papers/38540730 | PubMed |
| 38,489,266 | PAD4 controls tumor immunity via restraining the MHC class II machinery in macrophages. | Cell Rep | 2024 | https://conductscience.org/library/papers/38489266 | PubMed |
| 38,335,294 | The protein carboxymethyltransferase-dependent aspartate salvage pathway plays a crucial role in the intricate metabolic network of Escherichia coli. | Sci Adv | 2024 | https://conductscience.org/library/papers/38335294 | PubMed |
| 38,137,883 | Xeno Amino Acids: A Look into Biochemistry as We Do Not Know It. | Life (Basel) | 2023 | https://conductscience.org/library/papers/38137883 | PubMed |
| 37,920,756 | Electrochemical synthesis and antimicrobial evaluation of some N-phenyl α-amino acids. | RSC Adv | 2023 | https://conductscience.org/library/papers/37920756 | PubMed |
| 36,555,449 | Implications of Post-Translational Modifications in Autoimmunity with Emphasis on Citrullination, Homocitrullination and Acetylation for the Pathogenesis, Diagnosis and Prognosis of Rheumatoid Arthritis. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36555449 | PubMed |
| 36,539,894 | NAA60 (HAT4): the newly discovered bi-functional Golgi member of the acetyltransferase family. | Clin Epigenetics | 2022 | https://conductscience.org/library/papers/36539894 | PubMed |
| 36,389,721 | Biomarkers of autoimmunity and beta cell metabolism in type 1 diabetes. | Front Immunol | 2022 | https://conductscience.org/library/papers/36389721 | PubMed |
| 36,029,409 | Post-translational Modifications in Brain Diseases: A Future for Biomarkers. | Adv Exp Med Biol | 2022 | https://conductscience.org/library/papers/36029409 | PubMed |
| 34,827,739 | Emergence and Enhancement of Ultrasensitivity through Posttranslational Modulation of Protein Stability. | Biomolecules | 2021 | https://conductscience.org/library/papers/34827739 | PubMed |
| 34,140,951 | Citrullination and PAD Enzyme Biology in Type 1 Diabetes - Regulators of Inflammation, Autoimmunity, and Pathology. | Front Immunol | 2021 | https://conductscience.org/library/papers/34140951 | PubMed |
| 33,798,408 | Discovering the landscape of protein modifications. | Mol Cell | 2021 | https://conductscience.org/library/papers/33798408 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/337487
GET https://conductscience.org/api/papers/v1/337487/cited_by?page=2